Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Mar;51(3):295–299. doi: 10.1038/bjc.1985.42

Predictive chemosensitivity testing.

P R Twentyman
PMCID: PMC1976960  PMID: 3970809

Full text

PDF
296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buick R. N., Pollak M. N. Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res. 1984 Nov;44(11):4909–4918. [PubMed] [Google Scholar]
  2. Courtenay V. D., Mills J. An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. Br J Cancer. 1978 Feb;37(2):261–268. doi: 10.1038/bjc.1978.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Friedman H. M., Glaubiger D. L. Assessment of in vitro drug sensitivity of human tumor cells using [3H]thymidine incorporation in a modified human tumor stem cell assay. Cancer Res. 1982 Nov;42(11):4683–4689. [PubMed] [Google Scholar]
  4. Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
  5. Mattern J., Volm M. Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev. 1982 Dec;9(4):267–298. doi: 10.1016/s0305-7372(82)80041-8. [DOI] [PubMed] [Google Scholar]
  6. Potten C. S., Schofield R., Lajtha L. G. A comparison of cell replacement in bone marrow, testis and three regions of surface epithelium. Biochim Biophys Acta. 1979 Aug 10;560(2):281–299. doi: 10.1016/0304-419x(79)90022-2. [DOI] [PubMed] [Google Scholar]
  7. Rowley R., Hopkins H. A., Looney W. B. In vivo tumour-cell proliferation after adriamycin treatment. Br J Cancer. 1982 Mar;45(3):429–437. doi: 10.1038/bjc.1982.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Selby P., Buick R. N., Tannock I. A critical appraisal of the "human tumor stem-cell assay". N Engl J Med. 1983 Jan 20;308(3):129–134. doi: 10.1056/NEJM198301203080304. [DOI] [PubMed] [Google Scholar]
  9. Sondak V. K., Bertelsen C. A., Tanigawa N., Hildebrand-Zanki S. U., Morton D. L., Korn E. L., Kern D. H. Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res. 1984 Apr;44(4):1725–1728. [PubMed] [Google Scholar]
  10. Stephens T. C., Peacock J. H. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer. 1977 Sep;36(3):313–321. doi: 10.1038/bjc.1977.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sutherland R. M., Eddy H. A., Bareham B., Reich K., Vanantwerp D. Resistance to adriamycin in multicellular spheroids. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1225–1230. doi: 10.1016/0360-3016(79)90643-6. [DOI] [PubMed] [Google Scholar]
  12. Twentyman P. R. Experimental chemotherapy studies: intercomparison of assays. Br J Cancer Suppl. 1980 Apr;4:279–287. [PMC free article] [PubMed] [Google Scholar]
  13. Volm M., Wayss K., Kaufmann M., Mattern J. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Eur J Cancer. 1979 Jul;15(7):983–993. doi: 10.1016/0014-2964(79)90282-2. [DOI] [PubMed] [Google Scholar]
  14. Von Hoff D. D. "Send this patient's tumor for culture and sensitivity". N Engl J Med. 1983 Jan 20;308(3):154–155. doi: 10.1056/NEJM198301203080310. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES